Abstract
A method for simultaneous determination of buprenorphine (BUP), norbuprenorphine (NBUP), methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), cocaine, benzoylecgonine (BE), ecgonine methyl ester (EME), anhydroecgonine methyl ester (AEME), morphine, codeine, 6-acetylmorphine (6AM), heroin, 6-acetylcodeine (6AC), nicotine, cotinine, and trans-3′-hydroxycotinine (OH-cotinine) by liquid chromatography tandem mass spectrometry in oral fluid (OF) was developed and extensively validated. Acetonitrile (800 μL) and OF (250 μL) were added to a 96-well Isolute-PPT+protein precipitation plate. Reverse-phase separation was achieved in 16 min and quantification was performed by multiple reaction monitoring. The assay was linear from 0.5 or 1 to 500 μg/L. Intraday, interday, and total imprecision were less than 13% (n = 20), analytical recovery was 92–114% (n = 20), extraction efficiencies were more than 77% (n = 5), and process efficiencies were more than 45% (n = 5). Although ion suppression was detected for EME, cocaine, morphine, 6AC, and heroin (less than 56%) and enhancement was detected for BE and nicotine (less than 316%), deuterated internal standards compensated for these effects. The method was sensitive (limit of detection 0.2–0.8 μg/L) and specific (no interferences) except that 3-hydroxy-4-methoxyamphetamine interfered with AEME. No carryover was detected, and all analytes were stable for 24 h at 22 °C, for 72 h at 4 °C, and after three freeze–thaw cycles, except cocaine, 6AC, and heroin (22–97% loss). The method was applied to 41 OF specimens collected throughout pregnancy with a Salivette® OF collection device from an opioid-dependent BUP-maintained pregnant woman. BUP ranged from 0 to 7,400 μg/L, NBUP from 0 to 71 μg/L, methadone from 0 to 3 μg/L, nicotine from 32 to 5,020 μg/L, cotinine from 125 to 508 μg/L, OH-cotinine from 11 to 51 μg/L, cocaine from 0 to 419 μg/L, BE from 0 to 351 μg/L, EME from 0 to 286 μg/L, AEME from 0 to 7 μg/L, morphine from 0 to 22 μg/L, codeine from 0 to 1 μg/L, 6AM from 0 to 4 μg/L, and heroin from 0 to 2 μg/L. All specimens tested negative for EDDP and 6AC. This method permits a fast and simultaneous quantification of 16 drugs and metabolites in OF, with good selectivity and sensitivity.
Similar content being viewed by others
References
Drummer OH (2005) Forensic Sci Int 50(2–3):133–142
Bosker WM, Huestis MA (2009) Clin Chem 55(11):1910–1931
Mortier KA, Maudens KE, Lambert WE, Clauwaert KM, Van Bocxlaer JF, Deforce DL, Van Peteghem CH, De Leenheer AP (2002) J Chromatogr B Anal Technol Biomed Life Sci 779(2):321–330
Wood M, Laloup M, Ramirez Fernandez Mdel M, Jenkins KM, Young MS, Ramaekers JG, De Boeck G, Samyn N (2005) Forensic Sci Int (2–3):227–238
Kala SV, Harris SE, Freijo TD, Gerlich S (2008) J Anal Toxicol 32(8):605–611
Sergi M, Bafile E, Compagnone D, Curini R, D'Ascenzo G, Romolo FS (2009) Anal Bioanal Chem 393(2):709–718
Wylie FM, Torrance H, Anderson RA, Oliver JS (2005) Forensic Sci Int 150(2–3):191–198
Oiestad EL, Johansen U, Christophersen AS (2007) Clin Chem 53(2):300–309
Concheiro M, de Castro A, Quintela O, Cruz A, Lopez-Rivadulla M (2008) Anal Bioanal Chem 391(6):2329–2338
Simoes SS, Ajenjo AC, Franco JM, Vieira DN, Dias MJ (2009) Rapid Commun Mass Spectrom 23(10):1451–1460
Badawi N, Simonsen KW, Steentoft A, Bernhoft IM, Linnet K (2009) Clin Chem 55(11):2004–2018
Pil K, Raes E, Van den Neste T, Verstraete A (2007) Toxicological analyses in the DRUID epidemiological studies: analytical methods, target analytes and analytical cut-offs. Paper presented at the TIAFT annual meeting 2007
Dams R, Murphy CM, Choo RE, Lambert WE, De Leenheer AP, Huestis MA (2003) Anal Chem 75(4):798–804
Shakleya DM, Huestis MA (2009) Anal Bioanal Chem 395(7):2349–2357
Bentley MC, Abrar M, Kelk M, Cook J, Phillips K (1999) J Chromatogr B Biomed Sci Appl 723(1–2):185–194
Kataoka H, Inoue R, Yagi K, Saito K (2009) J Pharm Biomed Anal 49(1):108–114
Krouwer JS, Rabinowitz R (1984) Clin Chem 30(2):290–292
Commission E (2002) Off J Eur Communities L 221:8–36
Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P (2008) J Anal Toxicol 32(6):393–401
Guidance for Industry: Mass Spectrometry for Confirmation of the Identity of Animal Drug Residues #118 (2003) Food and Drug Administration. http://w.fda.gov/cvm. Accessed 19 July 2010
Nordgren HK, Holmgren P, Liljeberg P, Eriksson N, Beck O (2005) J Anal Toxicol 29(4):234–239
Allen KR (2006) Clin Toxicol (Phila) 44(2):147–153
Nakahara Y, Ishigami A (1991) J Anal Toxicol 15(3):105–109
Phillips SG, Allen KR (2006) J Anal Toxicol 30(6):370–374
Acknowledgement
This research was supported by the National Institutes of Health, Intramural Research Program, National Institute on Drug Abuse.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Concheiro, M., Gray, T.R., Shakleya, D.M. et al. High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 398, 915–924 (2010). https://doi.org/10.1007/s00216-010-3903-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-010-3903-5